Addex TherapeuticsADXN
13F holders, Q3 2025 (September 30)4holders −1
1new positions
2sold out
$9.32avg. 13F price*
At the end of Q3 2025, 4 institutions reported holding Addex Therapeutics Ltd. (ADXN) in their 13F filings, down 1 from Q2 2025. 1 opened new positions and 2 sold out. The largest holders were GAMMA Investing LLC ($1K), Rhumbline Advisers ($655) and SBI Securities Co., Ltd. ($47).
- Company
- Addex Therapeutics Ltd.
- CUSIP
- 00654J206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $9 |
| Exits | 2 | $2K |
All 13F filers, Q2 2025 → Q3 2025: 1 shares bought and 179 shares sold, net −178 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| GAMMA Investing LLC | 0.00% | No change | 121 | $1K |
| Rhumbline Advisers | 0.00% | No change | 72 | $655 |
| SBI Securities Co., Ltd. | 0.00% | No change | 5 | $47 |
| UBS Group AG | 0.00% | New | 1 | $9 |
"% of holder's portfolio" is ADXN's weight in each manager's 13F, not the share of Addex Therapeutics Ltd. the manager owns.